A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Fentanyl Citrate


Sosei Announces Successful Completion of AD 923  -  May 23, 2007
PipelineReview.com (press release),...single dose, crossover, randomised study of AD 923 versus Actiq® (oral transmucosal fentanyl citrate lozenge) and versus fentanyl citrate injection.

Aquavan(R) (Fospropofol Disodium) Injection Data Presented at ...  -  May 24, 2007
PipelineReview.com (press release),A total of 312 patients in 18 sites were pre-treated with fentanyl citrate (50 (mu)g) and then received either Aquavan 2.0 mg/kg, Aquavan 6.5 mg/kg or

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  Apr 25, 2007
MSN MoneyACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Watson Pharmaceuticals Reports First Quarter 2007 Results  -  May 1, 2007
Genetic Engineering News (press release),Other revenue increased $12.5 million to $13.2 million , due to the addition of commission revenue related to fentanyl citrate.

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  26 Apr 2007
MSN MoneyACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon Files Marketing Application for Approval of a Fentanyl ...  -  Mar 29, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally.

Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application  -  Apr 3, 2007
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Archimedes Pharma Announces Entry of ChiSys®-Based Intranasal ...  -  Apr 13, 2007
Oxfordshire Bioscience Network (press release),Our own lead product, Nasalfent for the treatment of breakthrough cancer pain, uses PecSys to optimise nasal delivery of fentanyl citrate and recently

Frost & Sullivan Commends Altea Therapeutics for Extending the ...  -  Apr 5, 2007
Drug Newswire (press release),...a fentanyl citrate transdermal patch that enables rapid and safe management of moderate to severe pain, and an apomorphine hydrochloride transdermal

Cephalon Files Marketing Application For Approval Of A Fentanyl ...  -  27 Mar 2007
Medical News Today (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally.

Market Report -- In Play (CEPH)  -  Mar 8, 2007
MSN Money2007, CEPH received a letter requesting information related to ACTIQ (oral transmucosal fentanyl citrate) and FENTORA (fentanyl buccal tablet) from

Burbs: Yonkers close to cable agreement with Verizon  -  Mar 1, 2007
White Plains Journal News,The increase is also related to strong sales of Fentanyl Citrate, a generic version of ACTIQ that was launched in late September.

Watson Pharma Posts Q4 Loss On Charges; Revenue Up 48%; Guides ...  -  Feb 27, 2007
Trading Markets,The growth was driven by increased sales of oxycodone HCl controlled- release tablets, addition of commission revenue related to fentanyl citrate as well as

Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2006 ...  -  Feb 27, 2007
PR Newswire (press release),...of oxycodone HCl controlled- release tablets, the addition of commission revenue related to fentanyl citrate and the addition of Andrx product revenue.

Cedarburg Pharmaceuticals Raises $3.5 Million in Series A-3 Financing  -  Feb 13, 2007
PR Web (press release),In addition, Cedarburg received European approval to market cancer pain relievers Fentanyl Base and Fentanyl Citrate. Grafton, WI (PRWEB) February 13,

Schmidt & Clark, LLP Contacted by Actiq Users Claiming Off-Label Use  -  Feb 24, 2007
PR Leap (press release),Approved by the US Food & Drug Administration (FDA) in 1998, Actiq (oral transmucosal fentanyl citrate) is a prescription medication indicated ONLY for the

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 12, 2007
Drug Newswire (press release),FENTORA, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection,

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 7, 2007
Yahoo! News (press release)FENTORA, ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic trioxide) injection, and VIVITROL®

Archimedes Pharma Enrols First Patient in Phase III Programme for ...  -  Feb 2, 2007
Oxfordshire Bioscience Network (press release),Nasalfent is an innovative fentanyl citrate nasal spray aimed at providing a fast, effective and convenient treatment for breakthrough cancer pain – sudden,

Cephalon Reports Record Sales and Earnings for 2006  -  Feb 15, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and numerous products internationally.

Altea Therapeutics Appoints Dr. William R. Good to its Board of ...  -  Feb 7, 2007
Business Wire (press release),...including for an insulin transdermal patch that provides continuous delivery of basal levels of insulin for people with diabetes, a fentanyl citrate

Prescription for abuse?  -  Jan 31, 2007
Newsday,The painkiller, Actiq, contains fentanyl citrate, a narcotic that packs more power than morphine. Some doctors have raised concerns that if patients misuse

Altea Therapeutics Enters into Research Agreements with Pharma ...  -  18 Jan 2007
Business Wire (press release),...including for an insulin transdermal patch that provides continuous delivery of basal levels of insulin for people with diabetes, a fentanyl citrate

Cephalon Announces Positive Results from Two Phase 3 Clinical ...  -  Jan 9, 2007
Yahoo! News (press release)...when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq®), to FENTORA,

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Wilson Paramedic Charged With Stealing Drugs  -  Dec 1, 2006
WRAL.com,Theresa B. Morris, 41, of La Grange, is charged with larceny by employee in connection with the theft of an undisclosed amount of fentanyl citrate,

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Yahoo! News (press release)FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic

EMS worker fired, arrested  -  Dec 1, 2006
Wilson Daily Times (subscription),Morris is accused of taking an undisclosed amount of fentanyl citrate, a narcotic similar to morphine, from a drug box belonging to Wilson County EMS.

Cephalon Inc. Granted Composition of Matter Patent Covering ...  Nov 7, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire (press release), Effects of papaverine and carbon dioxide alone or in combination ...  Oct 26, 2006
Anesthesia was induced with 30-µg/kg fentanyl citrate and 0.1-mg/kg midazolam and maintained with 0.3-µg/(kg · min) fentanyl citrate and 0.8-µg/(kg · min ... -The Journal of Thoracic and Cardiovascular Surgery Cephalon Announces Positive Results For FENTORA(TM) (fentanyl ...  Oct 12, 2006
...bioavailability of fentanyl in FENTORA, when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq ... -Medical News Today (press release), Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire

Wilson Paramedic Charged With Stealing Drugs  -  Dec 1, 2006
WRAL.com,Theresa B. Morris, 41, of La Grange, is charged with larceny by employee in connection with the theft of an undisclosed amount of fentanyl citrate,

Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of ...  -  Dec 4, 2006
Drug Newswire (press release),ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R)

Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of ...  -  Dec 4, 2006
Yahoo! News (press release)FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic

EMS worker fired, arrested  -  Dec 1, 2006
Wilson Daily Times (subscription),Morris is accused of taking an undisclosed amount of fentanyl citrate, a narcotic similar to morphine, from a drug box belonging to Wilson County EMS.

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire

Effectiveness of Fentanyl lozenges for breakthrough cancer pain  Aug 8, 2006
...medicine. The Fentanyl lozenge, known as oral transmucosal Fentanyl citrate, or OTFC, is also known by the brand name Actiq. The ... -Xagena.it

Cephalon Second-Quarter Sales Increase 58 Percent  Aug 3, 2006
...of $380-390 million, driven largely by strong gross sales of PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -MSN Money

Cephalon Second-Quarter Sales Increase 58 Percent  Aug 3, 2006
...of $380-390 million, driven largely by strong gross sales of PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... -Yahoo! News

Cephalon Expects Second Quarter 2006 Results to Exceed Prior ...  Jul 26, 2006
...by at least 40 percent driven largely by strong gross sales of PROVIGIL® (modafinil) Tablets [C-IV] and ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl ...  Jun 29, 2006
...the license and supply agreement with the company to have Cephalon manufacture for it a generic version of ACTIQ® (oral transmucosal fentanyl citrate) [C- II ... -Yahoo! News

Advances in the Pharmacologic Treatment of Chronic and ...  Jun 29, 2006
...of FEBT and found that this formulation provides more rapid and efficient delivery of fentanyl than oral transmucosal fentanyl citrate or swallowed FEBT. ... -Medscape (subscription)

Cephalon Receives Approvable Letter From FDA For FENTORA - Update  Jun 29, 2006
...the license and supply agreement with the company to have Cephalon manufacture for it a generic version of ACTIQ (oral transmucosal fentanyl citrate) (C- II ... -Trading Markets

Cephalon Announces Results from GABITRIL(R) Clinical Program in ...  Jun 26, 2006
...markets five proprietary products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL, ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... -Yahoo! News

Cephalon Announces Results from GABITRIL(R) Clinical Program in ...  Jun 26, 2006
...markets five proprietary products in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... -Drug Newswire



Cephalon's Fentanyl Effervescent Buccal Tablet Reduces Intensity ...  May 5, 2006
...in the United States: PROVIGIL(R) (modafinil) tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and ... - Medical News Today

Cephalon Reports First-Quarter Financial Results  May 2, 2006
...products in the United States: PROVIGIL (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon Receives Approvable Letter for NUVIGIL(TM) (armodafinil)  May 1, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)  Apr 24, 2006
...products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)  Apr 24, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and ... - PR Newswire





Tuesday Sheriff's Beat  Mar 29, 2006
Zack Smith filed a report Saturday, stating someone took some Actiq Fentanyl Citrate suckers. A medical Web site, www.cancer.org ... - Tahlequah Daily Press

Cephalon Oncology Compound Lestaurtinib (CEP-701) Granted Orphan ...  Apr 4, 2006
...in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride) Tablets, ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon Oncology Compound Lestaurtinib (CEP-701) Granted Orphan ...  Apr 4, 2006
...in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride) Tablets, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PharmaLive.com

Cephalon Granted Six Months of Pediatric Exclusivity for PROVIGIL  Mar 28, 2006
...four proprietary products in the United States: PROVIGIL, GABITRIL(R) (tiagabine hydrochloride) Tablets, ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PharmaLive.com

Cephalon Reports Outstanding Financial Results for 2005  Feb 14, 2006
In 2005, sales of PROVIGIL® (modafinil) Tablets [C-IV] increased 17 percent to $512.8 million; sales of ACTIQ® (oral transmucosal fentanyl citrate) [C-II ... - Yahoo! News

Cephalon, Inc. Announces Agreements With Barr Laboratories, Inc. ...  Feb 1, 2006
...patent infringement disputes in the United States related to PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... - Black Enterprise,

Cephalon, Inc. Provides Update on Regulatory Status of NUVIGIL(TM)  Feb 1, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... - Yahoo! News

Barr Announces Agreements With Cephalon, Inc. Regarding Settlement ...  Feb 1, 2006
...agreements to settle its pending patent infringement disputes in the United States related to Cephalon's ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - International News Service

Cephalon, Inc. Provides Update on Regulatory Status of NUVIGIL  Feb 2, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II ... - PharmaLive.com

Studies Confirm Effectiveness Of Fentanyl Lozenges For ' ...  Jan 25, 2006
...medicine. The fentanyl lozenge, known as oral transmucosal fentanyl citrate, or OTFC, is also known by the brand name Actiq. The ... - Medical News Today

Cephalon, Inc. Announces Agreements With Barr Laboratories, Inc. ...  Feb 1, 2006
...patent infringement disputes in the United States related to PROVIGIL(R) (modafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. ... - Black Enterprise

2d Plymouth paramedic fired  Jan 28, 2006
Police charge that Entenman removed morphine sulfate and fentanyl citrate, both controlled substances, from ambulances and replaced them with a saline solution ... - Philadelphia Inquirer

Horst Witzel, Dr.-Ing., to Retire From Cephalon Board of Directors  Jan 31, 2006
...products in the United States: PROVIGIL(R) (modafinil) [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II] and ... - PR Newswire

Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)  Jan 25, 2006
...markets four proprietary products in the United States: PROVIGIL, GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... - Yahoo! News

Horst Witzel, Dr.-Ing., to Retire From Cephalon Board of Directors  Jan 31, 2006
...products in the United States: PROVIGIL® (modafinil) [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal fentanyl citrate) [C-II] and ... - Yahoo! News


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional